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Abstract
Background: Osteopetrosis is a skeletal disorder of humans and animals characterized by the formation of overly 
dense bones, resulting from a deficiency in the number and/or function of bone-resorbing osteoclast cells. In cattle, 
osteopetrosis can either be induced during gestation by viral infection of the dam, or inherited as a recessive defect. 
Genetically affected calves are typically aborted late in gestation, display skull deformities and exhibit a marked 
reduction of osteoclasts. Although mutations in several genes are associated with osteopetrosis in humans and mice, 
the genetic basis of the cattle disorder was previously unknown.
Results: We have conducted a whole-genome association analysis to identify the mutation responsible for inherited 
osteopetrosis in Red Angus cattle. Analysis of >54,000 SNP genotypes for each of seven affected calves and nine 
control animals localized the defective gene to the telomeric end of bovine chromosome 4 (BTA4). Homozygosity 
analysis refined the interval to a 3.4-Mb region containing the SLC4A2 gene, encoding an anion exchanger protein 
necessary for proper osteoclast function. Examination of SLC4A2 from normal and affected animals revealed a ~2.8-kb 
deletion mutation in affected calves that encompasses exon 2 and nearly half of exon 3, predicted to prevent normal 
protein function. Analysis of RNA from a proven heterozygous individual confirmed the presence of transcripts lacking 
exons 2 and 3, in addition to normal transcripts. Genotyping of additional animals demonstrated complete 
concordance of the homozygous deletion genotype with the osteopetrosis phenotype. Histological examination of 
affected tissues revealed scarce, morphologically abnormal osteoclasts displaying evidence of apoptosis.
Conclusions: These results indicate that a deletion mutation within bovine SLC4A2 is associated with osteopetrosis in 
Red Angus cattle. Loss of SLC4A2 function appears to induce premature cell death, and likely results in cytoplasmic 
alkalinization of osteoclasts which, in turn, may disrupt acidification of resorption lacunae.
Background
Recessive genetic diseases have occasionally emerged
throughout the history of domestic cattle populations. In
part, this can be attributed to selective breeding practices
involving the extensive use of particular individuals or
pedigrees with demonstrated genetic merit. These prac-
tices can potentially lead to a reduction in the effective
population size and a subsequent increase in homozygos-
ity, thus allowing for the expression of recessive defect
phenotypes. The management of such disorders requires
the identification and culling of carrier individuals within
populations. Traditionally, when the genetic basis of a
recessive disorder is not known, identification of carriers
has been achieved through progeny testing or practicing
"pedigree prejudice", i.e., avoiding use of individuals of a
pedigree suspected to contain carriers. Unfortunately,
progeny testing is time-consuming and costly, and the
indiscriminate culling of pedigrees potentially results in
the loss of valuable germplasm. The development and use
of DNA-based tools for identifying carriers can alleviate
these issues, providing the impetus for mapping disease
loci. Tremendous advances in bovine genome character-
ization over the last two decades, including the comple-
tion of the bovine genome sequence [1] and the
development of thousands of molecular markers, have
provided the necessary resources for the efficient elucida-
tion of the genetic mutations underlying heritable disor-
ders.
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Osteopetrosis is a bone disorder known to affect
humans and other animals; in cattle, the disease can be
virally-induced [2,3], yet is typically inherited as a reces-
sive defect [4]. I t has been observed in several breeds,
including Angus, Red Angus, Hereford, Simmental and
Holstein [3-11]. In the 1960s, the number of reported
cases of osteopetrosis increased in frequency; during the
six-year period from 1967 to 1973, 123 affected Angus
calves were identified in the United States and Canada
[7]. Through the use of traditional progeny testing and
pedigree prejudice disease management methods, the
occurrence of osteopetrosis was moderated. However,
there has been a recent recurrence of the disease in the
Red Angus cattle. Laboratory-confirmed cases were iden-
tified in herds in Wyoming, Nebraska, Missouri, Kansas
and Saskatchewan [3,11], renewing economic and animal
welfare concerns among breeders. Moreover, the cause
for concern is exacerbated by the current use of repro-
ductive technologies such as artificial insemination and
embryo transfer that can rapidly disseminate deleterious
alleles.
The defining characteristics of osteopetrosis (also
known as "marble bone disease") are the defective activity
of osteoclasts, large multinucleated cells that resorb bone,
and the resulting accumulation of primary spongiosa in
marrow cavities (reviewed in, e.g., [12-14]). This results
in the formation of extremely dense, fragile bones. Vari-
ous secondary pathological conditions are also observed;
in cattle, affected calves are typically stillborn, slightly
premature (250-275 days of gestation), and often display
features including small body size, flat skull, impacted
molars, shortened mandible (brachygnathia inferior), and
protruding tongue ([3-11]; Figure 1). The osteopetrosis
phenotype indicates a defect in normal bone develop-
ment and remodeling, and more specifically, an imbal-
anced interplay between bone-forming osteoblasts and
bone-resorbing osteoclasts (reviewed in, e.g., [12-14]).
Osteopetrosis is known to result from a deficiency in the
number and/or function of osteoclasts; indeed, in cases
of inherited osteopetrosis in Angus cattle, few osteoclasts
have been observed [6,9,10], and any existing osteoclasts
lack surrounding zones of resorption [10].
Normally, differentiation of osteoclasts is induced by
the binding of a ligand on the surface of osteoblasts, to its
receptor on the surface of mononuclear osteoclast pre-
cursors (reviewed in, e.g., [12-14]). Following differentia-
tion, osteoclasts resorb bone through a three step
process, involving 1) cytoskeletal organization and the
formation of a ruffled border membrane, 2) acidification
of the resorption pit formed between the osteoclast and
the bone surface (Howship's lacuna), which serves to
demineralize inorganic bone material, and 3) proteolysis
of the organic matrix. The acidification step is achieved
through an active process in which protons produced in
the osteoclast by the action of carbonic anhydrase II
(CA2) are pumped across the ruffled border membrane
by a multi-subunit, vacuolar ATPase. Net charge in the
lacuna is neutralized by concurrent movement of chlo-
ride ions from the osteoclast through a channel com-
posed of the CLCN7 and OSTM1 proteins. To complete
the biochemical cycle and prevent toxic buildup in the
osteoclast of carbonate ions produced by CA2, an anion
exchanger on the external cell surface, SLC4A2, exports
carbonate ions and imports chloride ions. The subse-
quent proteolysis step is primarily mediated by the
enzyme cathepsin K (CTSK).
In humans, mutations in at least ten different genes are
known to cause osteopetrosis or osteopetrosis-like syn-
dromes [14], accounting for approximately 70% of osteo-
petrosis cases [15]. The molecular basis of the remaining
30% is unknown. Mutated genes include TNFSF11 and
TNFRSF11A, encoding the ligand/receptor pair involved
in osteoclast differentiation; ITGB3, encoding the β3
Figure 1 Phenotype of congenital osteopetrosis in affected Red 
Angus calves. A. Head of a late-term stillborn calf with inferior 
brachygnathia, short flattened skull and protruding tongue. B. Impact-
ed unerupted molar (M) and incisor teeth (I) in mandibles of an affect-
ed calf. C. Posterior aspect of skull with partial herniation of cerebellum 
through foramen magnum (arrow). D. Distal aspect of a sagittally sec-
tioned femur with a triangle of primary spongiosa (PS) resting on the 
distal growth plate and extending into the diaphysis. The normal mar-
row cavity is effaced. E. Marked compression of cerebral hemispheres 
(asterisk) due to excessive thickness of calvarium. The lesions shown in 
C and E (cerebellar herniation and compression of cerebral hemi-
spheres), combined with mineralization within the brain, are likely re-
sponsible for death of calves in utero with stillbirth.Meyers et al. BMC Genomics 2010, 11:337
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integrin involved in cytoskeletal organization; TCIRG1,
encoding the a3 subunit of the v-ATPase; CA2, encoding
carbonic anhydrase II; CLCN7 and OSTM1, encoding the
chloride channel and a channel stabilizing protein; and
CTSK, encoding cathepsin K. The remaining two genes,
PLEKHM1  ("pleckstrin homology domain containing,
family M member 1") and IKBKG  ("inhibitor of kappa
light polypeptide gene enhancer in B-cells, kinase
gamma"), are less well characterized.
In this study, we describe the clinical presentation and
histopathology of osteopetrosis in Red Angus cattle, the
mapping of the disease locus and the identification of a
~2.8-kb deletion mutation disrupting the SLC4A2 gene.
We further demonstrate complete concordance between
the homozygous deletion genotype and the osteopetrosis
phenotype, and confirm the presence of both normal and
mutant SLC4A2 transcripts in a known carrier of the dis-
ease.
Results
Clinical presentation and histopathology
Thirteen calves displaying the osteopetrosis phenotype
were acquired throughout the course of this study; all
calves exhibited typical gross lesions ([3-11]; Figure 1).
Tissues of affected calves were examined for evidence of
transplacental infection with bovine viral diarrhea virus
(BVDV), a recognized infectious cause of osteopetrosis
[2,3]; no BVD virus was detected (data not shown). Fur-
thermore, pedigree analysis of affected calves revealed
common ancestry on both maternal and paternal sides of
the pedigree, thus implicating a genetic basis of disease.
Five affected calves were further subjected to histologi-
cal examination. A marked reduction in the number of
osteoclasts and osteoblasts in affected bone were consis-
tently observed. Where present, osteoclasts were small,
irregularly shaped and exhibited pale cytoplasm (Figure
2A-D). Howship's lacunae appeared shallow and in many
cases osteoclasts were either absent or displaced from the
resorptive surface. Additionally, cellular changes sugges-
tive of osteoclast apoptosis were occasionally encoun-
tered (Figure 2D). Similar to the osteoclasts, osteoblasts
w e r e  a l s o  m a r k e d l y  d i m i n i s h e d  i n  n u m b e r  a n d ,  w h e r e
present, were small and flat with pale cytoplasm (Figure
2E). Histological examination of brain revealed consistent
changes including widespread neuronal chromatolysis in
cranial nerve nuclei of medulla oblongata, axonal spher-
oid formation in reticular formation, and perivascular
mineralization in subependymal neuropil ventral to lat-
eral ventricles (Figure 2F-G).
Mapping of the osteopetrosis disease locus
To identify the defective gene associated with osteopetro-
sis, we obtained DNA from the first seven affected Red
Angus calves acquired, their carrier parents and nine nor-
mal Red Angus controls. We initially examined the
bovine orthologs of genes implicated in human disease
for molecular variation associated with the osteopetrosis
phenotype. The coding regions of the bovine TNFSF11,
TNFRSF11A, ITGB3, TCIRG1, CA2, CLCN7, OSTM1,
CTSK  and  PLEKHM1  genes were amplified and rese-
quenced from the DNA of normal, carrier and affected
animals (data not shown). No obvious causative variation
was detected, thus warranting further investigation by
whole-genome association analysis.
We then used the Illumina BovineSNP50 BeadChip
array [16] to genotype each individual for >54,000 evenly-
distributed SNP markers and subsequently performed
genome-wide association and homozygosity analyses to
determine the most likely chromosomal position of the
disease locus. The basic case/control association analysis
option of PLINK [17] was used to compare allele frequen-
cies between the affected and normal animals. The most
significant SNP associations were localized to the telo-
meric end of bovine chromosome 4 (BTA4; Figure 3). As
this genomic location did not coincide with the locations
of any of the original candidate genes, those genes were
Figure 2 Histopathology of bone and brain in late-term aborted 
Red Angus calves. A-D (distal aspect, femur): Abnormal morpholo-
gy of few remaining osteoclasts persisting in bone. A. Osteoclast with 
scant cytoplasm and no obvious Howship's lacuna. B. Osteoclast with 
scant, lightly vacuolated cytoplasm that partially occupies lacuna. C. 
Osteoclast with nuclear degeneration. Myeloid cells are interposed be-
tween osteoclast and lacuna. D. Two osteoclasts associated with frag-
ment of cartilage. One (black arrow; bottom left) is relatively normal. 
The other (white arrow; top right) exhibits nuclear changes consistent 
with apoptosis. E (mid-section, rib). Scant, widely separated osteo-
blasts (arrowhead) associated with osteoid. F-G (brain, medulla ob-
longata at obex). F. Chromatolysis of large neurons (asterisks). G. 
Widespread axonal spheroids in reticular formation (asterisks).Meyers et al. BMC Genomics 2010, 11:337
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not examined further. Forty-two of the 100 SNPs with the
highest significance of association were located between
108.37 Mb and 123.97 Mb on BTA4; the remaining 58
SNPs were distributed among sixteen other chromo-
somes, with a range of 1 to 8 SNPs per chromosome.
Marker BTB-01 162852, located at 115.70 Mb, yielded the
highest observed chi-square value of 32.00, while a group
of five markers, located between 115.72 Mb and 119.72
Mb, showed the next highest chi-square value of 28.21
(Table 1). An allele frequency of 1 was observed among
the affected animals, indicating that all affected animals
were homozygous for a shared haplotype of these six
markers that was less commonly observed among control
individuals. The homozygosity mapping option of PLINK
was also used to detect runs of homozygous SNPs from
each individual, group individuals with overlapping
regions of homozygosity and determine a consensus seg-
ment of matching alleles. The results of this analysis were
consistent with the association analysis, revealing an
extended region of homozygosity at the telomeric end of
BTA4 that was unique to the group of seven affected
calves. The combined group of overlapping segments
Table 1: Most significant SNP associations detected by case/control analysis.
Marker name Chr Marker position (bp) MAF (cases) MAF (controls) Chi-square value P-value
BTB-01162852 4 115,699,819 1 0 32.00 1.54E-08
ARS-BFGL-NGS-24470 4 115,725,375 1 0.05556 28.21 1.09E-07
ARS-BFGL-NGS-43056 4 116,685,970 1 0.05556 28.21 1.09E-07
ARS-BFGL-NGS-80140 4 117,048,104 1 0.05556 28.21 1.09E-07
ARS-BFGL-NGS-108296 4 119,189,609 1 0.05556 28.21 1.09E-07
ARS-BFGL-NGS-95252 4 119,272,013 1 0.05556 28.21 1.09E-07
"Chr" indicates the Bos taurus chromosome (BTA) number. "MAF" denotes the minor allele frequency, and is individually reported for case 
(affected) individuals and control (normal) individuals. The chi-square is the result of a basic allele test, with one degree of freedom (df). P-value 
is the asymptotic p-value for the basic allele test.
Figure 3 Genome-wide case/control association analysis for the osteopetrosis disease locus. Chromosome and relative position (Mb) are plot-
ted on the x-axis, and the chi-square value calculated from a basic allelic test (1 df) is plotted on the y-axis. Any chi-square values less than 1.0 were 
not included. As shown, the most significant SNP associations are localized to the telomeric end of BTA4.Meyers et al. BMC Genomics 2010, 11:337
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spanned the chromosomal region between 90.65 Mb and
124.13 Mb, whereas the consensus segment included
markers between 115.67 Mb and 119.32 Mb. Manual
inspection of the overlapping segments revealed that the
consensus region is actually bounded by heterozygous
SNP genotypes at markers BTB-01163185 and ARS-
BFGL-NGS-73498, defining a ~3.8-Mb interval from
115.61 Mb to 119.42 Mb (Additional file 1 Table S1). The
nearest heterozygous genotypes on each side of this inter-
val were located at 112.73 Mb and 119.76 Mb.
Based on a conservative interpretation of the associa-
tion and homozygosity analyses, we further examined the
BTA4 chromosomal region from 107.14 Mb to 123.48 Mb
through the use of novel microsatellite markers devel-
oped from the bovine draft genome sequence (NCBI
Btau_4.0). All seven affected animals and their parents
were genotyped for 46 microsatellite markers with an
average spacing of 0.36 Mb (Additional file 2 Table S2). In
agreement with the SNP data, haplotype analysis revealed
recombination events at 112.55 Mb and 119.40 Mb. Sub-
sequent genotyping of an additional osteopetrosis calf
that was born while the study was underway identified a
recombination event at 119.00 Mb, providing slight
refinement of the distal end of the interval. A combined
analysis of the microsatellite and SNP marker data, high-
lighting the refined ~3.4-Mb interval, is shown in Figure
4. Genotype data for the overall region of homozygosity,
including the consensus segment of 87 informative mark-
ers, are provided in Additional file 1 Table S1.
Candidate gene selection and analysis
T h e  m o s t  r e c e n t  b o v i n e  g e n o m e  a s s e m b l y  ( N C B I
Btau_4.0) indicates that the ~3.4-Mb chromosomal seg-
m e n t  o f  i n t e r e s t  c o n t a i n s  6 6  g e n e s .  A m o n g  t h e s e ,  w e
identified two strong functional candidate genes,
ATP6V0E2  and SLC4A2, at 117.02 Mb and 117.92 Mb,
respectively.  ATP6V0E2  ("ATPase, H+ transporting, V0
subunit e2") encodes the e2 isoform of an essential sub-
unit of a vacuolar-ATPase proton pump [18]. As men-
tioned previously, this type of pump is used during the
acidification process of bone resorption, and mutations in
the a3 subunit of the osteoclast v-ATPase are associated
with osteopetrosis in humans and mice [19-21]. It has
also been shown that inactivation of the d2 subunit
results in mild osteopetrosis in mice [22]. Although the
exact configuration of the osteoclast v-ATPase has not
been determined, e2 transcripts have been detected in
osteoclasts, suggesting possible involvement in osteoclast
function [23]. The other, more compelling candidate
gene, SLC4A2 ("solute carrier family 4, anion exchanger,
member 2"), encodes the anion exchanger protein located
in the basolateral membrane of osteoclasts that is respon-
sible for clearing excess carbonate ions and replenishing
the supply of chloride ions during lacunar acidification.
Three reports published during the course of this study
have indicated that, in mice, SLC4A2 is required for both
the differentiation and bone-resorbing function of osteo-
clasts, and importantly, mice lacking this protein exhibit
severe osteopetrosis [24-26].
In an effort to identify molecular variation associated
with osteopetrosis, we amplified and resequenced each
candidate gene from DNA samples from normal, carrier
and affected individuals, and subsequently compared the
sequences of affected calves with the others. Although a
number of SNPs were detected within ATP6V0E2, none
appeared to be causative. One SNP was identified within
coding sequence; however, this nucleotide substitution
was not detected in the affected animals. Four SNP alleles
unique to the affected calves were identified within the 3'
untranslated region (UTR); however, the biological signif-
icance of this variation was not obvious. Efforts to rese-
quence  SLC4A2  revealed the potential for both an
unannotated first exon and a large deletion mutation in
the affected calves. While searching the NCBI database of
Expressed Sequence Tags (dbEST; http://
www.ncbi.nlm.nih.gov/dbEST/) for ESTs with sequence
similarity to the human SLC4A2  transcript (GenBank
accession number NM_003040), one EST (GenBank
accession number DV927173) sequence contained a tran-
scriptional start site located almost 2.5 kb upstream of
the first predicted exon of the bovine SLC4A2 gene (Gen-
Bank accession XM_586817). Comparison of the bovine
genomic and EST sequences suggested that the true
SLC4A2  gene sequence contains an untranslated first
exon and a partially translated second exon. While
attempting to amplify fragments encompassing the 5' end
of the SLC4A2  coding sequence (i.e., the start codon
within the newly-annotated exon 2), allele-specific ampli-
fication was observed; no PCR product was generated
from the affected calf templates. Subsequent use of rede-
signed primers for several fragments in the region also
failed to yield product from the affected calf samples,
warranting further examination of the upstream
sequence. Downstream of the allele-specific amplicon,
amplification was observed equally among all animal
samples for the remainder of the SLC4A2 gene sequence.
No seemingly causative variation was observed in these
sequences; only one synonymous nucleotide substitution
specific to the affected calves was observed in exon 14.
These results suggest that a deletion of the 5' portion of
SLC4A2 may be responsible for the osteopetrosis pheno-
type.
To characterize the breakpoint of the suspected dele-
tion, primers were designed to amplify a series of evenly-
spaced, short fragments upstream of the allele-specific
amplicon (Figure 5A). Amplification patterns were then
compared between normal and affected individuals.
Upon observing equal amplification (i.e., from all ani-Meyers et al. BMC Genomics 2010, 11:337
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mals) of fragments located on both sides of the allele-spe-
cific amplicon, different combinations of primer pairs,
consisting of a forward primer from the upstream region
and a reverse primer from the downstream region, were
used to amplify across the breakpoint. Using one such
primer pair, a product of ~700 bp was amplified from
affected individuals; direct sequencing and examination
of this product revealed a ~2,781 bp deletion (Figure 5A;
Additional file 3 Figure S1). The sequence missing from
the affected calves encompasses nearly one-third of
intron 1, all of exon 2, all of intron 2 and nearly half of
exon 3 (based on the new annotation derived from EST
sequence). Importantly, the exon 2 sequence contains the
distal portion of the 5' UTR as well as the first 17 codons.
Figure 4 Combined homozygosity analysis. An ideogram of bovine chromosome 4 (BTA4; adapted from http://www.marc.usda.gov/genome/ht-
mls/LinkageMap.jsp?Species=bos&Chromosome=4) is displayed alongside an enlargement of the extended regions of homozygosity detected in 
each of eight affected calves. Individual homozygous segments are depicted as gray rectangles, and the chromosomal positions (in Mb) of each 
bounding marker are indicated at the top and bottom of each segment. The homozygous segment on the far right represents one animal that was 
only genotyped for microsatellite markers between 107.14 Mb and 123.48 Mb; therefore, the extent of homozygosity proximal to 107.14 Mb is un-
known, as indicated by the question mark. The overall region of homozygosity, from 90.65 Mb to 124.13 Mb, is bounded by dashed lines. The consen-
sus region of homozygosity shared by all affected calves, from 115.61 Mb to 119.00 Mb, is bounded by solid black lines. Thus, the osteopetrosis disease 
locus has been mapped to this 3.4-Mb region. The overall figure has been adapted from [43].Meyers et al. BMC Genomics 2010, 11:337
http://www.biomedcentral.com/1471-2164/11/337
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Although the exon 3 sequence is only partially deleted,
the removal of the splice acceptor for this exon should
result in removal of the entire exon (57 codons) from any
transcript produced from the mutated genomic
sequence.
SLC4A2 transcript analysis
To test the hypothesis that the biological consequence of
the deletion mutation is the formation of a transcript
lacking exons 2 and 3, we performed 5' RACE to examine
the cDNA ends of any SLC4A2 transcripts present in a
known osteopetrosis carrier. RNA used for this analysis
was isolated from the monocyte fraction of blood, which
is known to contain mononuclear osteoclast precursors
[27]. As expected of a heterozygous individual, both nor-
mal and mutant transcripts were detected. Normal tran-
scripts displayed sequential splicing of the newly-defined
exon 1 to exons 2, 3 and 4, whereas mutant transcripts
Figure 5 Characterization of the SLC4A2 deletion mutation. Each figure represents the first six of twenty-three SLC4A2 exons in the context of the 
genomic sequence. Each exon is displayed as a box, with the corresponding exon number indicated above. White coloring represents 5' untranslated 
region (UTR), whereas gray coloring represents coding sequences; therefore, the black line within exon 2 represents the start codon. Figure 5A depicts 
the determination of the deletion breakpoint. PCR amplicons designed to characterize the region are shown as fragments below the gene, and ar-
rowheads represent primers. Fragments marked with an X failed to amplify from affected calf samples. The circled primers were eventually used to 
amplify across the breakpoint in affected calves. Direct sequencing of the resulting product revealed the breakpoint locations indicated by dashed 
vertical lines. Comparison with the normal SLC4A2 genomic sequence determined a deletion size of 2781 bp, as indicated. Figure 5B depicts the effect 
of the deletion mutation on splicing of SLC4A2 transcripts. The dashed box represents the genomic sequence missing from affected calf samples. The 
dotted lines above the gene reflect splicing of normal transcripts; splicing proceeds from exon 1 to 2 to 3 to 4, and so on. The dotted lines below the 
gene reflect splicing of mutant transcripts; due to deletion of exon 2 and the splice acceptor for exon 3, splicing proceeds from exon 1 to 4, and so 
on. Both transcript types were produced by a confirmed carrier cow, as detected by 5' RACE.Meyers et al. BMC Genomics 2010, 11:337
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displayed direct splicing of exon 1 to exon 4 (Figure 5B).
Although variable transcriptional start sites were
observed among 5' RACE products, no other transcript
types were evident.
Population analysis
To further investigate or validate the association of the
observed deletion mutation with the osteopetrosis phe-
notype, we designed an assay to genotype cattle for the
mutation. A simple PCR-based assay was developed,
based on the differential amplification of the normal and
mutant alleles using a trio of primers (Figure 6; Addi-
tional file 3 Figure S1). A forward primer, used in combi-
nation with a reverse primer located in the deleted
sequence, yields product only from the normal allele
because the reverse priming site is missing from the
mutant allele. The same forward primer, used in combi-
nation with a reverse primer located across the break-
point, yields product only from the mutant allele because
the normal product would be too long (~3 kb) to amplify
under assay conditions. Using this assay, all seven of the
original affected calves, plus all of six additional affected
calves born during the course of the study were found to
be homozygous for the mutation. Furthermore, any avail-
able parent samples were heterozygous for the deletion,
thus demonstrating complete concordance between the
deletion genotype and the disease phenotype.
In addition to analysis of animals with known genotype
status, we genotyped 451 phenotypically normal Red
Angus cattle for the mutation. Although more heterozy-
gous individuals were identified, no animals were found
to be homozygous for the mutation. Included in this anal-
ysis were 265 sires representing the diversity within the
Red Angus breed; 25 of these 265 were identified as car-
rier individuals, corresponding to an allele frequency of
0.047. Since the Red Angus breed was developed from
(and continues to incorporate germplasm from) Black
Angus, we also tested 578 Black Angus sires but did not
detect the mutation among these animals.
Discussion
In this study , we have used the latest bovine SNP chip
technology and association analysis to map the osteopet-
rosis disease locus to a ~3.4-Mb interval at the telomeric
end of bovine chromosome 4. Both a case/control associ-
ation analysis and a homozygosity analysis implicated
essentially the same chromosomal segment on BTA4,
centered at the 117-118 Mb location. Molecular examina-
tion of the SLC4A2 functional candidate gene at this posi-
tion not only resulted in a new annotation of this gene,
but also revealed a large deletion mutation within this
genomic sequence. By analyzing SLC4A2  transcripts
present in a known osteopetrosis carrier, we have con-
firmed the presence of a previously unannotated first
exon identified in dbEST, and defined the biological rele-
vance of the SLC4A2 deletion mutation. We have further
demonstrated that this mutation is concordant with the
osteopetrosis phenotype. Thus, we believe we have iden-
tified the causative mutation for osteopetrosis in Red
Angus cattle.
At the level of genomic DNA, the osteopetrosis muta-
tion results in the deletion of 2781 bp of the SLC4A2 gene
sequence, and thus the removal of roughly one-third of
intron 1, the entire sequences of exon 2 and intron 2, and
nearly half of exon 3. This has been confirmed by the suc-
cessful amplification and sequencing of the genomic frag-
ment spanning the deletion breakpoint junction in
affected individuals, followed by comparison of the
mutant sequence with the normal SLC4A2  sequence.
Inspection of the genomic sequence encompassing the
deletion mutation did not reveal an obvious mechanism
for spontaneous chromosomal breakage at this location.
Deletions of this type can often be attributed to genomic
instability; typically this instability is associated with the
formation of alternative, non-B DNA secondary struc-
tures [28]. As a general rule, DNA sequences that form
such secondary structures are repetitive [28]; yet, analysis
of the SLC4A2  sequence with RepeatMasker http://
www.repeatmasker.org did not yield masked sequences
within the immediate vicinity of either chromosomal
break (Additional file 3 Figure S1). The nearest repetitive
sequences are at least 550 bp from either side of each
breakage point, and only a few short (30-70 bp) repeats
Figure 6 SLC4A2 deletion mutation genotyping assay. Represen-
tative PCR amplicons for each deletion mutation genotype, separated 
by agarose gel electrophoresis, are shown. From left to right, the first 
lane represents a known osteopetrosis carrier individual, the second 
and third lanes represent normal individuals and the fourth and fifth 
lanes represent osteopetrosis-affected calves. As shown, both normal 
(475 bp) and mutant (330 bp) alleles are amplified from a heterozygous 
individual, whereas only the appropriate allele is amplified from ho-
mozygous normal and mutant individuals.Meyers et al. BMC Genomics 2010, 11:337
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were detected within the deleted sequence. Thus, the
cause of the deletion mutation is unclear.
At the level of transcription, the deletion mutation
results in the production of mutant transcripts lacking
exons 2 and 3. This was expected, given the deletion of
exon 2 as well as the splice acceptor for exon 3, and has
been confirmed by analysis of 5' RACE products from a
known osteopetrosis carrier cow. Despite evidence of
multiple SLC4A2 transcripts (referred to as types "a", "b"
and "c") in other species, only normal and mutant type "a"
transcripts were detected by 5' RACE. The ~4.4-kb type
"a" transcript is the longest known SLC4A2 isoform, and
has been detected in the human, mouse and rat [29-32].
Unlike the other transcript types, this isoform is ubiqui-
tously expressed, and has been shown to be upregulated
in osteoclasts [26]. It consists of exons 1 through 23, and
the start codon is located within exon 2. Slightly shorter,
~4.2-kb "b" isoforms have also been described in the
human, mouse and rat [29-32]. Both "b1" (human, mouse
and rat) and "b2" (human and mouse) isoforms initiate
transcription from alternative first exons, containing
alternative start codons, that are located in intron 2.
Expression of these transcripts appears to be predomi-
nant in the stomach, but also at reduced levels in other
tissues; in humans, the relative abundance of these tran-
scripts appears to be approximately 10% of that of the "a"
isoform [31]. Therefore it is possible that no type "b" tran-
scripts were detected in this study as a result of either a
lack of expression in osteoclasts or expression at a level
insufficient to be observed among the clones picked. If
type "b" isoforms are present in bovine osteoclasts, it is
expected that the deletion mutation would result in the
removal of both alternative first exons as well as exon 3.
Finally, a third, ~3.8-kb "c" type isoform has been
detected in both mice and rats [29,32]. Similar to the "b"
isoforms, "c1" (mouse and rat) and "c2" (mouse) isoforms
initiate from alternative first exons; these exons are
located in intron 5, and splice to exon 6, which contains
the start codon. The "c1" isoform has been described as
stomach-specific, whereas the "c2" isoform can be
detected at low levels in other tissues [29]. In this case,
the lack of observation of a "c" transcript type in cattle,
and likewise in human, is likely due to the fact that the
start codon utilized in mouse and rat sequences is not
conserved. Both the human and bovine sequences con-
tain a methionine codon further downstream within exon
6, yet, based on a lack of detection in either species, this
does not appear to be a translational start. Although the
nucleotides surrounding this codon may represent an
adequate Kozak sequence, they do not comprise a strong
initiator sequence [33].
At the level of translation, then, it is expected that the
deletion mutation would result in a complete lack of
bovine SLC4A2 protein expression. Although this has not
been confirmed in this study, much can be inferred by
comparison with recent studies of SLC4A2 knockout
(Ae2-/-) mice. Mice deficient in all SLC4A2 isoforms, as a
result of targeted replacement of exons 14-17 with A the
neomycin resistance gene, fail to resorb bone and develop
severe osteopetrosis [25,26]. The gross and histological
f e a t u r e s  o b s e r v e d  i n  A e 2 - / -  m i c e  a r e  s i m i l a r  t o  t h o s e
observed in osteopetrosis-affected calves; Ae2-/- mice
exhibit improper bone marrow cavity formation [24-26],
growth retardation[24-26,34], early lethality (typically by
age of weaning) [26,34], abnormal mandibles [25] and
impaired tooth development [25,34]. In both SLC4A2-
deficient mice and cattle, abnormal osteoclast morphol-
ogy is apparent; however, histological differences are
observed. In these mice, osteoclasts are enlarged with
abundant cytoplasm [25,26], whereas the cattle osteo-
clasts examined here appeared small with a reduced vol-
ume of cytoplasm. Additionally, Ae2-/- knockout mice
exhibit similar numbers of osteoclasts in bone when com-
pared to wild-type mice, whereas we noted a marked
reduction in the number of osteoclasts in the affected calf
samples. This finding is consistent with previous reports
of osteopetrosis in cattle [6,9,10].
R e c e n t  s t u d i e s  i n  m i c e  h a v e  s h o w n  t h a t  t h e  a n i o n
exchanger SLC4A2 is necessary for proper osteoclast
function [24-26]. This finding suggests that, during nor-
mal bone development and remodeling, SLC4A2 is the
osteoclast anion exchanger required to exchange bicar-
bonate ions produced by carbonic anhydrase II for chlo-
ride ions that are then transported across the ruffled
border membrane, along with protons, to acidify the
resorption lacuna and demineralize bone. It is expected,
then, that a lack of SLC4A2 protein expression would
prevent bone resorption due to the resulting lack of acidi-
fication. Indeed, studies in mice have shown that
SLC4A2-deficient osteoclasts are unable to form an acidi-
fied vacuole [26], and in this study, the observed resorp-
tion lacunae are particularly shallow. However, unlike
human osteoclasts harboring mutations in either car-
bonic anhydrase II [35] or the v-ATPase proton pump
[19], which also mediate the acidification activity of
osteoclasts, SLC4A2-deficient mouse osteoclasts appear
morphologically abnormal and lack a ruffled border
membrane [24-26]; thus, a bone resorption defect due to
a lack of SLC4A2 may be more severe. Additional func-
tional complications may result from the improper alka-
l i n i z a t i o n  o f  t h e  o s t e o c l a s t  c y t o p l a s m .  I t  h a s  b e e n
suggested that the expression of other proteins involved
in bone resorption may be affected by a loss of SLC4A2,
and indeed, abnormal expression of β3 integrin has been
observed in SLC4A2-deficient mouse osteoclasts [26]. As
β3 integrin is involved in the cytoskeletal organization
step of the bone resorption process, this may explain theMeyers et al. BMC Genomics 2010, 11:337
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defect in ruffled border membrane formation. It has also
been proposed that SLC4A2 may have multiple functions
in the osteoclast, as another member of this protein fam-
ily, SLC4A1, can function as a cytoskeletal anchor protein
[26]. Thus, loss of SLC4A2 may affect the bone-resorbing
function of osteoclasts through a number of different
mechanisms; however, the effect of the cattle SLC4A2
deletion mutation on acidification activity is currently
unclear.
Studies in mice have also shown that loss of SLC4A2
may affect the viability of osteoclasts. Although compari-
son of normal and Ae2-/- mice reveals similar numbers of
osteoclasts, nearly four times as many SLC4A2-deficient
osteoclasts show signs of apoptosis [26]; this has been
attributed to cytoplasmic alkalinization. This finding is
consistent with results reported here, and likely explains
the marked reduction in osteoclasts observed in affected
calves at the time of abortion. Histological examination
suggests that, in cattle homozygous for the SLC4A2 dele-
tion mutation, osteoclasts form but die prematurely by
apoptosis. Several Howship's lacunae lacking associated
osteoclasts were detected in the affected calf samples,
suggesting that osteoclasts were once present, yet few
osteoclasts were observed and cytologic features of apop-
tosis were evident among them. Unexpectedly, histologi-
cal examination also revealed reduced numbers of
osteoblasts in calf samples. Based on the increased bone
density observed in these animals, osteoblasts were
clearly present during fetal development. Thus, loss of
S L C 4 A 2  m a y  a l s o  a f f e c t  t h i s  c e l l  t y p e .  I n d e e d ,  s t u d i e s
have reported intercellular communication among bone
cells which regulates the balance between bone formation
and resorption [reviewed in 36]. Interestingly, a pH-
dependent model of osteoclast-osteoblast communica-
tion has been proposed in which SLC4A2 plays a key role
[36,37]. In this model, extracellular alkalinization result-
ing from SLC4A2-mediated bicarbonate ion secretion
activates osteoblast enzymes that degrade inhibitors of
bone formation. Perhaps, then, a lack of osteoblast activa-
tion, due to the loss of SLC4A2 and apoptosis of osteo-
clasts, leads to subsequent death of osteoblast cells.
Temporal differences in the death of these cell types
could account for the overgrowth of bones observed in
the affected calves.
It is interesting that no mutations in human SLC4A2
have been described to date in the context of osteopetro-
sis or any other hereditary disease. Approximately 30% of
human patients with osteopetrosis have unrecognized
molecular defects [15,38]; thus, it may be worthwhile to
examine these orphan human osteopetrotic syndromes
for mutations in SLC4A2. However, it has also been sug-
gested that such human SLC4A2 mutations may result in
embryonic lethality in humans due to ubiquitous expres-
sion of this protein, and as a result, will likely remain
undetected [25]. For reasons unknown, mice and cattle
lacking  SLC4A2  exhibit differences in age at lethality;
SLC4A2-deficient mice tend to die as weanlings, whereas
cattle are aborted in late gestation. The abortion of
affected calves is likely due to severe changes in brain,
specifically compression of brainstem, herniation of cere-
bellum through foramen magnum, degeneration of cau-
dal cranial nerve neurons, axonal spheroid formation,
and mineralization of neuropil at the floor of the lateral
ventricles. All of these features appear to be secondary to
compression by the thickened osteopetrotic cranial vault.
They have not been described, to our knowledge, as a
congenital or antenatal defect in severe forms of inherited
osteopetrosis in human patients.
We have demonstrated that the deletion mutation gen-
otype is fully associated with the osteopetrosis phenotype
in Red Angus cattle. Through the development and use of
simple, PCR-based assay to detect the deletion mutation,
we accurately identified 100% of affected calves and their
carrier parents as such based on genotype. Due to this
accuracy, the genotyping assay can now be used as a
molecular diagnostic tool for the identification of other
osteopetrosis carriers within the Red Angus population.
In this study, population analysis identified 25 carriers
among 265 AI sires; this allele frequency suggests that the
frequency of the mutation in the Red Angus population
may be as high as 4.7%. As a caveat, however, this estima-
tion includes a group of animals submitted by one
breeder in which nearly 30% were identified as carriers.
Taking this into consideration, a more realistic estimate is
likely to be on the order of 1.5-2%. Results of all tested AI
sires have been reported to the Red Angus Association of
America for dissemination to breeders. The accessibility
of this information, as well as any future carrier informa-
tion generated through the use of the diagnostic test, will
allow cattle producers to make educated decisions for
herd management that not only facilitate disease preven-
tion, but also enable retention of valuable germplasm.
While assessing the Red Angus population, we identi-
fied a carrier bull that was born in 1964. This finding is
consistent with the emergence of the disorder; however,
as no ancestors of this bull were available for testing, the
identity of the proband remains unknown. It is interesting
to note that this oldest known carrier bull is a descendant
of Black Angus grandparents, yet the deletion mutation
could not be detected among 578 Black Angus individu-
als tested. This suggests that, if the same deletion muta-
tion causes osteopetrosis in both Black and Red Angus
cattle, the frequency of the mutated allele among Black
Angus cattle is less than 0.001. Alternatively, it is possible
that at least one other bovine mutation causing osteopet-
rosis exists. Any additional mutations that may cause this
disorder in other breeds of cattle are currently unknown.Meyers et al. BMC Genomics 2010, 11:337
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Conclusions
We have identified a deletion mutation in the bovine
SLC4A2 gene that is associated with osteopetrosis in Red
Angus cattle. Discovery of such a mutation supplements
current knowledge regarding the role of the SLC4A2
anion exchanger in the bone resorption process and fur-
thers understanding of osteoclast biology. Additionally,
the development of a DNA-based assay that can serve as
a molecular diagnostic test for osteopetrosis carriers will
facilitate the eradication of this disorder from the Red
Angus population while minimizing loss of genetic merit.
Furthermore, we have demonstrated the effectiveness of
the bovine SNP chip technology for whole-genome asso-
ciation analyses and elucidation of causative genetic
mutations, even when relatively few samples are available.
Thus, this strategy can be applied toward the discovery of
other disease loci in cattle and the goal of broadening the




The diseased animals used were generally stillborn or
died prior to discovery, or rarely were euthanized shortly
after birth by the owners prior to being supplied to the
authors for the study, so no animal care and use guide-
lines apply. Samples from unaffected animals were
obtained from commercial semen companies or had
blood collected by licensed veterinarians on the property
and under the supervision of the owners of the animals.
Thirteen Red Angus calves exhibiting the osteopetrosis
phenotype were identified at the Wyoming State Veteri-
nary Laboratory (WSVL), the Nebraska Veterinary Diag-
nostic Center and the private practice of Lou Scott, DVM.
Detailed gross and histological examination was per-
formed on five affected calves (four male and one female)
following abortion in late gestation (215-230 days; nor-
mal gestation is 283 days). Tissues were fixed routinely in
10% neutral buffered formalin. Bone from axial and apen-
dicular skeleton was decalcified. Five micrometer-thick
sections of tissue were cut and stained with hematoxylin
and eosin, and examined histologically.
DNA samples isolated from the first seven affected
calves obtained were used for both SNP genotyping and
fragment analysis of novel microsatellite markers. DNA
from an additional affected calf born during the study
was only genotyped by fragment analysis. DNA from an
additional five affected calves, also born later in the study,
were included in population analyses as well as validation
of the deletion mutation assay. The seven affected calf
samples used for whole-genome association analysis were
offspring of two sires and seven dams; samples were col-
lected from all nine parents. The two sires were full sib-
lings; one bull sired three affected calves, and the other
sired four. Five of these seven calves were produced from
parent-offspring matings. Samples from an additional six
affected calves and five putative carriers were also
obtained. The nine control Red Angus samples used for
S NP  ge no typi ng as  we l l as som e  AI  sir e  s am ples we r e
obtained from the United States Meat Animal Research
Center (USMARC) "2000 Bull Project". Other Angus and
Red Angus AI sire samples used for population analyses
were acquired from members of the National Association
of Animal Breeders (NAAB) or from Gordon Jones
(Western Kentucky University).
Samples were acquired in the form of blood, semen or
tissue. DNA was typically isolated using commercially
available kits (Zymo Research or QIAGEN) according to
manufacturer instructions.
Mapping of the osteopetrosis disease locus
Genomic DNA samples acquired from the first seven
affected Red Angus calves, their carrier parents and nine
normal Red Angus controls were genotyped using the
Illumina BovineSNP50 BeadChip array [16]. Whole-
genome association and homozygosity analyses were per-
formed using PLINK [17]. The "--assoc" option was used
to conduct the basic case/control association analysis; for
this analysis, the "--cow" command was used to specify
the Bos taurus species, and the "--maf 0.01" command
was used to set a minor allele frequency inclusion thresh-
old of 0.01. The "--homozyg" option was used to conduct
the homozygosity analysis; the number of allowed
heterozygous SNPs per window was set to zero ("--
homozyg-window-het 0") and the number of allowed
missing genotypes was set to twelve ("--homozyg-win-
dow-missing 12"). The grouping of segments of matching
alleles was achieved using the "--homozyg-group" and "--
homozyg-match 1" commands. The homozygosity analy-
sis reported in Additional file 1 Table S1 was adapted
from a verbose group file created using the "--homozyg-
verbose" command.
Microsatellite data generated from fragment analysis
was added to the verbose SNP genotype homozygosity
file. The genotype file was manually inspected to identify
heterozygous markers.
Microsatellite marker development and fragment analysis
Novel microsatellite markers were identified using the
o n l i n e  S i m p l e  S e q u e n c e  R e p e a t  I d e n t i f i c a t i o n  T o o l
(SSRIT; http://www.gramene.org/db/searches/ssrtool) to
screen the bovine genome sequence (NCBI Btau_4.0) for
repeats with a minimum length of ten per dimer. Frag-
ment analysis genotyping was performed using a multi-
plex of primers, including one standard primer and one
M13-tagged primer per marker primer pair, plus one flu-
orescently-labeled (PET™, NED™, VIC® or 6-FAM™ dye;
Applied Biosystems) M13 primer [39]. Markers wereMeyers et al. BMC Genomics 2010, 11:337
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grouped into multiplex PCR reactions based on color and
size combinations. PCR was performed in a 10-μl reac-
tion volume containing ~30-50 ng of template DNA, 1×
PCR buffer (containing 1.5 mM MgCl2; QIAGEN), 200
μ M  e a c h  d N T P  ( F e r m e n t a s ), 0.25 μM each standard
primer, 0.0125 μM each M13-tagged primer, 0.15-0.25
μM each fluorescently-labeled M13 primer and 0.25-0.35
U HotStar Taq DNA polymerase (QIAGEN). Typical PCR
cycling parameters included an initial denaturation step
of 95°C for 5 min followed by 35 cycles of 94°C for 1 min,
58°C for 1.5 min, and 72°C for 1.5 min, plus a final exten-
sion step of 72°C for 1 hr. Primer sequences and marker
information are provided in Additional file 2 Table S2.
Multiplex PCR products were combined and purified
using Promega Wizard® SV96 binding plates as described
[40]. GeneScan™ 500 LIZ® size standard (Applied Biosys-
tems) was added to 10-μl aliquots prior to loading on an
ABI 3730 capillary sequencer. Automated allele-calling
was performed using GeneMarker® (SoftGenetics, LLC)
software. Allele calls were checked manually and edited if
necessary.
Primer design and PCR
Primers used in this study were designed using Primer
Designer 2 (Scientific and Educational Software). Stan-
dard PCR and cycle sequencing reactions were typically
performed as previously described [41]. Primer
sequences for ATP6V0E2  and  SLC4A2  candidate gene
sequencing are provided in Additional file 4 Table S3.
Candidate gene analysis
Candidate gene fragments were amplified and re-
sequenced from a select group of eight Red Angus sam-
ples of known or suspected genotype status; two samples
represented normal animals, two samples represented
affected calves and four samples represented putative
carrier individuals. These sequences were then aligned
and compared to the genomic sequence to identify poly-
morphisms. First, the genomic sequence of each candi-
date gene was masked of repetitive elements using
RepeatMasker http://www.repeatmasker.org. Primers
were then designed in non-repetitive sequence to amplify
and sequence overlapping ~1-kb DNA fragments. PCR
was performed, and products were treated using a 1:10
dilution of ExoSAP-IT® (USB Corporation) as described
[41]. Approximately 100-200 ng of each purified PCR
product was then sequenced directly, using each primer
used for amplification, as described [41]. Sequencing
product was then purified by size exclusion with Sepha-
dex™ G-50 Fine beads (Amersham Biosciences) prior to
loading on an ABI 3730 capillary sequencer (Applied Bio-
systems). Sequences were analyzed and polymorphisms
were detected using CodonCode Aligner http://
www.codoncode.com/aligner/ or Phred/Phrap/Consed
software [42]. The genomic sequence of each candidate
gene was included as a reference. All sequence chromato-
grams were visually inspected to confirm detected poly-
morphisms.
Transcript analysis
Total RNA was isolated from blood taken from a cow
known to be heterozygous for the SLC4A2  deletion.
Whole blood was first mixed with approximately six vol-
umes of an erythrocyte lysis buffer (155 mM ammonium
chloride, 10 mM potassium bicarbonate and 0.1 mM
EDTA). The remaining leukocytes were then pelleted and
resuspended in TRIzol® Reagent (Invitrogen), and RNA
was extracted according to the manufacturers' instruc-
tions. Following RNA purification using the RNeasy Mini
Kit (QIAGEN), the 5' cDNA ends of bovine SLC4A2 were
generated using the FirstChoice® RNA Ligase Mediated
Rapid Amplification of cDNA Ends (RLM-RACE) Kit
(Ambion). Gene-specific primers were designed within
exons 4, 5, 7 and 8 based on a hybrid sequence of an avail-
able bovine SLC4A2  EST (GenBank accession number
DV927173) and the predicted coding sequence (GenBank
accession number XM_586817). The EST sequence was
used to obtain the 5' UTR sequences of exons 1 and 2 and
the predicted sequence was used for the coding regions of
exons 2-23. Following RNA modification and reverse
transcription, the supplied 5'-RACE-Outer primer was
used with exon 5 primer SLC4A2_5R_743C (5'-GTGGA-
GAGGGACTGGTGGTT-3'), exon 7 primer
SLC4A2_7R_1060C (5'-CCCAGGAACATCCT-
CAAACC-3') or exon 8 primer SLC4A2_8R_1213C (5'-
TTTGTCCAGCAGCAGCTCAT-3') to amplify primary
5' cDNA end products; these products were then used as
template in secondary, nested PCR reactions using the
supplied 5'-RACE-Inner primer with either exon 4
primer SLC4A2_4R_468C (5'-TGGATGTGATGGGAA-
GACTG-3'), exon 5 primer SLC4A2_5R_743C and exon 7
primer SLC4A2_7R_1060C, respectively. Nested PCR
products were cloned using the TOPO® TA cloning kit for
sequencing (Invitrogen, pCR®4-TOPO®  cloning vector).
Cloned cDNA end products were analyzed by restriction,
and clones of differing insert size were bidirectionally
sequenced as described [41]. Sequences were analyzed
using CodonCode Aligner.
Deletion mutation genotyping assay
A deletion mutation genotyping assay was developed
based on the differential amplification of the normal and
mutant alleles using a trio of primers. A forward primer
(5'-GGGAAGGGAAGCACTAAGACT-3') was used in
combination with a reverse primer located in the deleted
sequence (5'-TGGAGAGACAGCAGCAGAGAT-3') to
yield a 475 bp product representing the normal allele, and
a second reverse primer located across the deletionMeyers et al. BMC Genomics 2010, 11:337
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breakpoint (5'-GGTGGATGTGATGGGAAGACT-3') to
yield a 330 bp product representing the mutant allele
(Figure 6; Additional file 3 Figure S1). PCR was typically
performed in a 20-μl reaction volume containing 30-50
ng of template DNA, 1× PCR buffer (containing 1.5 mM
MgCl2; QIAGEN), 200 μM each dNTP (Fermentas), 0.5
μM each primer, and 0.25 U HotStarTaq DNA poly-
merase (QIAGEN). PCR cycling parameters included an
initial denaturation step of 95°C for 5 min followed by 31
cycles of 94°C for 45 s, 63°C for 45 s, and 72°C for 45 s,
plus a final extension step of 72°C for 5 min. Products
were separated on a 1.6% agarose, 0.5 × TBE gel with a 4
cm well-to-well distance (Figure 6).
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